CENCORA INC (COR)
US03073E1055 - Common Stock
YieldBoost COR From 1% To 6.6% Using Options
These S&P500 stocks are moving in today's session
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Wednesday as we examine the latest happenings in today's session.
Cencora Breaks Below 200-Day Moving Average - Notable for COR
Cencora Closes $1.8 Billion Senior Notes Offering
Cencora vs. Solana: Price Relationship Crosses Threshold
McKesson Stock Gets A RS Rating Lift To 75
The Relative Strength (RS) Rating for McKesson stock jumped into a new percentile Wednesday, as it got a lift from 70 to 75.
Cardinal Health Stock Sees IBD RS Rating Improve To 71
In a welcome move, Cardinal Health stock saw its Relative Strength (RS) Rating rise from 65 to 71 on Friday.
Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results
Noteworthy Tuesday Option Activity: IRBT, CVNA, COR
Cencora Expands Enterprise Leadership Team with Two Senior Appointments
Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release
May 2025 Options Now Available For Cencora (COR)
Tuesday Sector Laggards: Healthcare, Utilities
Interesting COR Put And Call Options For September 2025
Why Walgreens Boots Alliance Fell Another 22% in August
The retail pharmacy giant faces ever-mounting headwinds.
Is the Temu Hype Warranted?
School's in and we've also got a look at the challenges teachers face while saving for retirement.
Drug distributors strike $300 million opioid settlement with US health plans
(Reuters) -The three largest U.S. drug distributors have agreed to pay $300 million to resolve claims by health insurers and benefit plans that they helped fuel the deadly U.S. opioid epidemic, according to court papers filed on Friday. The proposed class action settlement with McKesson Corp, Cencora Inc and Cardinal Health Inc was disclosed in a filing in federal court in Cleveland, Ohio, and requires a judge's approval. Paul Geller, a lawyer for the plaintiffs, said in a statement that Friday's deal covered third-party payers like union funds that "largely paid for the overprescribed and overmarketed pills and for the treatment required when their plan beneficiaries inevitably suffered opioid use disorder."
Is Cash Flow a Problem for Walgreens Boots Alliance?
There are plenty of red flags surrounding the business.
Cencora Elects Frank Clyburn to Its Board of Directors
Health Care Giant McKesson Dives Amid Big Revenue Miss
McKesson earnings beat estimates, but the drug and health supplies distribution giant badly missed sales estimates. MCK stock dived.